Evidence map›Paper›PMID 20077160›Full record

ReviewImmunologic research2010

Genetic and biochemical regulation of CD4 T cell effector differentiation: insights from examination of T cell clonal anergy.

Christopher J Gamper, Jonathan D Powell

Abstract readReview
In one paragraph

Review in Immunologic research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Christopher J GamperDepartment of Oncology, Sidney Kimmel Cancer Center, School of Medicine, Johns Hopkins University, CRB 1, Room 443, Baltimore, MD 21231, USA.
Jonathan D Powell
Sidney Kimmel Comprehensive Cancer Center · US

Funding

A central role for mTOR in Determining T Cell Activation versus ToleranceR01AI077610 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POWELL, JONATHAN D · 2009 to 2019
$4.0M
A2a receptor engagement promotes T cell toleranceR01CA114227 · NCI · JOHNS HOPKINS UNIVERSITY · PI POWELL, JONATHAN D · 2006 to 2010
$1.3M
NCI NIH HHS 1R01CA114227-01NCI NIH HHS R01 CA114227NIAID NIH HHS R01 AI077610
6 · The paper itself

Abstract

The two-signal model of T cell activation states that antigen recognition by TCR provides a tolerogenic signal (termed Signal 1) unless the T cell receives simultaneous costimulation (Signal 2) that permits antigen recognition to prime activation. Our efforts to characterize genetic and biochemical factors resulting from Signal 1 alone have identified signaling molecules, transcription factors, and an epigenetic regulator that each contribute to the anergic phenotype observed. However, our most striking finding is that the same factors identified using anergy to model T cell activation versus tolerance also participate in determining the outcome of the effector phenotype of fully activated T cells. We summarize our own findings and other recent advances in the genetic and biochemical understanding of T cell activation, tolerance, and plasticity in this review.

Indexed as

Cell DifferentiationGene Expression RegulationAnimalsCD4-Positive T-LymphocytesClonal AnergyHumansLymphocyte ActivationMiceSignal TransductionT-Lymphocytes

Identifiers

PMID20077160
PMCPMC2892254
OpenAlexW1999236892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.